BBC NEWS Americas Africa Europe Middle East South Asia Asia Pacific Arabic Spanish Russian Chinese Welsh

 You are in: Business
Front Page 
UK Politics 
Market Data 
Your Money 
Business Basics 
Talking Point 
In Depth 

Commonwealth Games 2002

BBC Sport

BBC Weather

Friday, 20 July, 2001, 14:37 GMT 15:37 UK
Merck's profits up, but growth slows
Pills being poured into a container
Merck's profits aren't flowing as freely as it would like
The US pharmaceuticals company Merck has announced a rise in its second-quarter profits of 5%, a slower rate of increase than in previous quarters.

But the results were in line with expectations following the profits warning Merck issued on 22 June.

Net income rose to $1.82bn from $1.72bn in the same quarter last year, and earnings per share came in at 78 cents.

Profits have been hit by disappointing sales of its Vioxx arthritis treatment and by the strength of the dollar, which has lowered the value of sales in countries with weaker currencies.

Not fast enough

Sales of Voixx reached $725m in the quarter. That's a 53% rise from the second quarter in 2000, but analysts had been hoping for faster growth this year.

Sales of Merck's biggest selling drug Zocor - a cholesterol treatment - were up 5% on the previous year to $1.36bn.

Analysts are concerned that sales of Merck's main five drugs are not rising fast enough to compensate for a number of patent expirations.

Merck's shares hit an all time high in November last year, but have since fallen back nearly 30%. The stock dropped nearly 9% when the company issued its profits warning last month.

See also:

22 Jun 01 | Business
Drug giant warns of lower profits
20 Apr 01 | Business
New drugs boost Merck's profits
07 Mar 01 | Africa
US firm offers cheap Aids drugs
17 Jul 01 | Business
Drugs firms beat the slowdown
Internet links:

The BBC is not responsible for the content of external internet sites

Links to more Business stories are at the foot of the page.

E-mail this story to a friend

Links to more Business stories